Numerous court decisions over the past decade – such as Amgen Inc. v. Sanofi from the US Supreme Court and Juno Therapeutics, Inc. et al. v.

Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous an ...

Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...

It is possible that horses were forced to feed on the carcasses of dead birds, the natural carriers of H5N1, as much of ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...

Ontario is funding Beyfortus, an injectable ready-made antibody that fights RSV for up to six months for all infants under 12 months of age. Babies born at Sault Area Hospital during the RSV season ...

Uliledlimab is an antibody designed to target CD73. The development pause will also allow I-Mab to allow data from an ongoing ...

WuXi upgraded its WuXiBody platform in bispecific antibody discovery to address the growing global demand for these complex ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.